193 related articles for article (PubMed ID: 34153047)
1. Role of the inhibitor of serine peptidase 2 (ISP2) of Trypanosoma brucei rhodesiense in parasite virulence and modulation of the inflammatory responses of the host.
Levy DJ; Goundry A; Laires RSS; Costa TFR; Novo CM; Grab DJ; Mottram JC; Lima APCA
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009526. PubMed ID: 34153047
[TBL] [Abstract][Full Text] [Related]
2.
Costa TFR; Goundry A; Morrot A; Grab DJ; Mottram JC; Lima APCA
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614101
[TBL] [Abstract][Full Text] [Related]
3. The ecotin-like peptidase inhibitor of Trypanosoma cruzi prevents TMPRSS2-PAR2-TLR4 crosstalk downmodulating infection and inflammation.
Costa TFR; Catta-Preta CMC; Goundry A; Carvalho DB; Rodrigues NS; Vivarini AC; de Abreu MF; Reis FCG; Lima APCA
FASEB J; 2024 Mar; 38(6):e23566. PubMed ID: 38526868
[TBL] [Abstract][Full Text] [Related]
4. Mouse experiments demonstrate differential pathogenicity and virulence of Trypanosoma brucei rhodesiense strains.
Kipkorir LW; John TK; Owino OB; John O; Robert S; Daniel M; Owino AV
Exp Parasitol; 2021 Sep; 228():108135. PubMed ID: 34284027
[TBL] [Abstract][Full Text] [Related]
5. Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major.
Eschenlauer SC; Faria MS; Morrison LS; Bland N; Ribeiro-Gomes FL; DosReis GA; Coombs GH; Lima AP; Mottram JC
Cell Microbiol; 2009 Jan; 11(1):106-20. PubMed ID: 19016791
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing of Trypanosoma brucei reveals introgression between subspecies that is associated with virulence.
Goodhead I; Capewell P; Bailey JW; Beament T; Chance M; Kay S; Forrester S; MacLeod A; Taylor M; Noyes H; Hall N
mBio; 2013 Aug; 4(4):. PubMed ID: 23963174
[TBL] [Abstract][Full Text] [Related]
7. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.
Sternberg JM; Maclean L
Parasitology; 2010 Dec; 137(14):2007-15. PubMed ID: 20663245
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
9. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
10. Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.
Maclean L; Odiit M; Macleod A; Morrison L; Sweeney L; Cooper A; Kennedy PG; Sternberg JM
J Infect Dis; 2007 Dec; 196(11):1620-8. PubMed ID: 18008245
[TBL] [Abstract][Full Text] [Related]
11. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878
[TBL] [Abstract][Full Text] [Related]
12. The pathogenicity of blood stream and central nervous system forms of
Ndungu K; Thuita J; Murilla G; Kagira J; Auma J; Mireji P; Ngae G; Okumu P; Gitonga P; Guya S; Mdachi R
F1000Res; 2022; 11():260. PubMed ID: 38162635
[No Abstract] [Full Text] [Related]
13. Plasma cytokines quantification among
Kamoto K; Chiwaya A; Nambala P; Chammudzi P; Senga E; Chisi J; Matovu E; Musaya J
Malawi Med J; 2021 Dec; 33(4):230-235. PubMed ID: 35291381
[TBL] [Abstract][Full Text] [Related]
14. The human serum resistance associated gene is ubiquitous and conserved in Trypanosoma brucei rhodesiense throughout East Africa.
Gibson W; Backhouse T; Griffiths A
Infect Genet Evol; 2002 May; 1(3):207-14. PubMed ID: 12798017
[TBL] [Abstract][Full Text] [Related]
15. Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system.
Dubois ME; Demick KP; Mansfield JM
Infect Immun; 2005 May; 73(5):2690-7. PubMed ID: 15845470
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome profiles of Trypanosoma brucei rhodesiense in Malawi reveal focus specific gene expression profiles associated with pathology.
Nambala P; Noyes H; Namulondo J; Nyangiri O; Alibu VP; Nerima B; MacLeod A; Matovu E; Musaya J; Mulindwa J;
PLoS Negl Trop Dis; 2024 May; 18(5):e0011516. PubMed ID: 38701067
[TBL] [Abstract][Full Text] [Related]
17. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
Picozzi K; Carrington M; Welburn SC
Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
[TBL] [Abstract][Full Text] [Related]
18. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
Mutomba MC; Li F; Gottesdiener KM; Wang CC
Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection.
Naessens J; Kitani H; Nakamura Y; Yagi Y; Sekikawa K; Iraqi F
Clin Exp Immunol; 2005 Mar; 139(3):405-10. PubMed ID: 15730385
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
